Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 SEK | -3.09% | +2.29% | -10.13% |
16/04 | Mendus AB Announces Board Changes | CI |
27/03 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.13% | 45.04M | |
+29.73% | 48.16B | |
-1.27% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.16% | 25.59B | |
-23.07% | 18.96B | |
+8.38% | 12.92B | |
+28.92% | 12.03B | |
-2.07% | 11.77B |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- Sweden’s Mendus Receives European Medicines Agency Certification for Cancer Vaccine